With our singular focus on autoimmune diseases with unmet needs, we deliver transformative therapies that enable patients to live their fullest lives.

We are a proven, passionate team committed to changing the trajectory of autoimmune diseases. Find out more about who we are, what drives us, and what we’ve accomplished so far.

At Aurinia, we embrace the possibility to change the trajectory of autoimmune diseases with unmet needs. With a growing pipeline and a dynamic team of proven experts, our work is patient-centric and driven by a sense of urgency.

Patients are at the heart of everything we do – and we are committed to empowering them to take charge of their health through education and advocacy. See the latest steps we are taking to support health equity and improve the lives of people living with autoimmune diseases.

Autoimmune diseases place a huge strain on patients and caregivers. Finding better ways to reduce the burden is what drives all of our research and development efforts. Learn more about our latest studies and how we are partnering with leading healthcare providers and institutions to advance the science and develop transformative new treatment options.

Lupus nephritis will occur in up to half of all people with lupus – and can lead to irreversible kidney damage or even kidney failure if poorly controlled. Read on to learn more about the disease and the resources developed by Aurinia to help individuals living with lupus nephritis and those who care for them navigate this complex disease.

From its inception, Aurinia has been driven to transform the lives of people living with autoimmune diseases.

Our founders understood the urgency of developing solutions for patients suffering from lupus nephritis. Working tirelessly, they assembled a team of passionate individuals with expertise in drug research, development and commercialization, and sought like-minded partners to enable the delivery of transformative treatments to as many patients as possible, as soon as possible.

This entrepreneurial energy continues to fuel our commitment to changing the trajectory of autoimmune disease and our drive to ensure health equity for all patients.